(firstQuint)Efficacy and Safety Study of Beclometasone/Formoterol Single Inhaler in Patients With COPD.

 The purpose of this study is to evaluate the long-term efficacy and safety of the fixed combination beclometasone/formoterol pMDI in a twice daily regimen in patients with stable severe COPD.

 Patients are randomised to receive either beclometasone/formoterol or budesonide/formoterol DPI or formoterol DPI during 48 weeks of treatment.

.

 Efficacy and Safety Study of Beclometasone/Formoterol Single Inhaler in Patients With COPD@highlight

To evaluate the 1-year efficacy and safety of the fixed combination beclometasone/formoterol pMDI in a twice daily regimen in patients with stable severe COPD.

